IAS Gyan

Daily News Analysis

ADDERALL

17th October, 2022 Health

Disclaimer: Copyright infringement not intended.

Context

  • The US Food and Drug and Drug Administration (FDA) announced a shortage of Adderall.

About

  • Adderall is the brand name for the formulation that consists of a combination of dextroamphetamine and amphetamine.
  • It is drug for the treatment of ADHD and narcolepsy, a sleep condition that causes daytime sleepiness.

 

Attention-deficit/hyperactivity disorder

ADHD is one of the most common neurodevelopmental disorders of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD may have trouble paying attention, controlling impulsive behaviors (may act without thinking about what the result will be), or be overly active. It may contribute to low self-esteem, troubled relationships and difficulty at school or work. Treatments include medication and talk therapy. Many adults remain undiagnosed, and symptoms can cause difficulty at work, home or relationships. Symptoms can appear different at older ages, for example, hyperactivity can appear as extreme restlessness.

 

  • Adderall belongs to the class of drugs known as stimulants and increases the levels of dopamine and norepinephrine in the brain.
  • For people diagnosed with ADHD, Adderall can help improve focus, concentration, impulse control and hyperactivity, because of its effects on the central nervous system.

https://indianexpress.com/article/explained/explained-global/why-the-us-is-facing-a-shortage-of-adderall-used-to-treat-adhd-8210883/